Cefiderocol Pharmacokinetics in a Patient Receiving Continuous Venovenous Hemodiafiltration.
CRRT
CVVHDF
antimicrobial dosing
cefiderocol
continuous renal replacement therapy
pharmacodynamics
pharmacokinetics
Journal
Open forum infectious diseases
ISSN: 2328-8957
Titre abrégé: Open Forum Infect Dis
Pays: United States
ID NLM: 101637045
Informations de publication
Date de publication:
Jul 2021
Jul 2021
Historique:
received:
10
03
2021
accepted:
12
05
2021
entrez:
12
7
2021
pubmed:
13
7
2021
medline:
13
7
2021
Statut:
epublish
Résumé
Antimicrobial dosing in patients receiving continuous renal replacement therapy is a continued clinical challenge. We describe a case of a patient receiving cefiderocol 2 g intravenously every 8 hours as a 3-hour infusion for a multidrug-resistant
Identifiants
pubmed: 34250190
doi: 10.1093/ofid/ofab252
pii: ofab252
pmc: PMC8266675
doi:
Types de publication
Case Reports
Langues
eng
Pagination
ofab252Informations de copyright
© The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
Références
Int J Antimicrob Agents. 2018 Feb;51(2):206-212
pubmed: 29111435
Antimicrob Agents Chemother. 2021 Feb 17;65(3):
pubmed: 33257454
J Clin Pharmacol. 2017 May;57(5):584-591
pubmed: 27874971
Pharmacotherapy. 2019 Nov;39(11):1066-1076
pubmed: 31549737
Int J Antimicrob Agents. 2019 Apr;53(4):408-415
pubmed: 30415002
Acta Anaesthesiol Scand. 2012 Feb;56(2):147-57
pubmed: 22092254
Pharmacotherapy. 2016 May;36(5):e30-e33
pubmed: 27012450
J Antimicrob Chemother. 2016 Mar;71(3):670-7
pubmed: 26645269
Int J Antimicrob Agents. 2008 Apr;31(4):345-51
pubmed: 18313273
J Antimicrob Chemother. 2018 Mar 1;73(3):564-568
pubmed: 29216348
Curr Opin Infect Dis. 2019 Dec;32(6):647-655
pubmed: 31567737
Antimicrob Agents Chemother. 2018 Feb 23;62(3):
pubmed: 29311072
Clin Infect Dis. 2016 Dec 15;63(12):1615-1618
pubmed: 27624958
Clin Infect Dis. 2019 Nov 13;69(Suppl 7):S552-S558
pubmed: 31724042